Tissue-specific and reversible RNA interference in transgenic mice
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Genetically engineered mice provide powerful tools for understanding mammalian gene function. These models traditionally rely on gene overexpression from transgenes or targeted, irreversible gene mutation. By adapting the tetracycline (tet)-responsive system previously used for gene overexpression, we have developed a simple transgenic system to reversibly control endogenous gene expression using RNA interference (RNAi) in mice. Transgenic mice harboring a tet-responsive RNA polymerase II promoter driving a microRNA-based short hairpin RNA targeting the tumor suppressor Trp53 reversibly express short hairpin RNA when crossed with existing mouse strains expressing general or tissue-specific 'tet-on' or 'tet-off' transactivators. Reversible Trp53 knockdown can be achieved in several tissues, and restoring Trp53 expression in lymphomas whose development is promoted by Trp53 knockdown leads to tumor regression. By leaving the target gene unaltered, this approach permits tissue-specific, reversible regulation of endogenous gene expression in vivo, with potential broad application in basic biology and drug target validation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the outcome of endogenous p53 reactivation can be senescence and/or cell death depending on the tumour type 35,141,142”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“Tet-regulated gene overexpression systems were initially developed for use in cultured cell”
Identification of tissue-specific microRNAs from mouse
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00809-6 · Cited by 3,355 · cited 1×
“siRNA production was inhibited by addition of doxycycline to the drinking water, with no effect on the levels of the endogenous liver-specific microRNA miR-122 (ref”
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Self-citationSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“Our results are generally consistent with recent studies from our group and other group”
Self-citationRestoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 1×
“Our results are generally consistent with recent studies from our group and other group”
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677 · cited 1×
“In developing this approach, we were concerned that the levels of tet transactivator produced in existing mouse strains would be insufficient to drive functional shRNA expression or, alternatively, that overexpression of the exogenous microRNA would saturate the RNAi machinery leading to off-target effects as has rece…”
Genetic transformation of mouse embryos by microinjection of purified DNA.
Gordon, J. W., Scangos, G. A., Plotkin, D. J., Barbosa, J. A., & Ruddle, F. H. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7380 · Cited by 1,435
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
Conditional control of gene expression in the mouse
Lewandoski, M. (2001) · Nature Reviews Genetics · doi:10.1038/35093537 · Cited by 781
Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.
Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C., Lübbert, H., & Bujard, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10933 · Cited by 778
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.
Furth, P. A., St Onge, L., Böger, H., Gruss, P., Gossen, M., Kistner, A., Bujard, H., & Hennighausen, L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9302 · Cited by 770
Hochedlinger, K., Yamada, Y., Beard, C., & Jaenisch, R. (2005) · Cell · doi:10.1016/j.cell.2005.02.018 · Cited by 747
Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century
Capecchi, M. R. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1619 · Cited by 684
Cre-lox-regulated conditional RNA interference from transgenes
Ventura, A., Meissner, A., Dillon, C. P., McManus, M., Sharp, P. A., Van Parijs, L., Jaenisch, R., & Jacks, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403954101 · Cited by 625
Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in Mice
Sotillo, R., Hernando, E., Díaz-Rodríguez, E., Teruya-Feldstein, J., Cordón-Cardo, C., Lowe, S. W., & Benezra, R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.019 · Cited by 612
Self-citationModeling the Therapeutic Efficacy of p53 Restoration in Tumors
Martins, C. P., Brown-Swigart, L., & Evan, G. I. (2006) · Cell · doi:10.1016/j.cell.2006.12.007 · Cited by 600 · cited 1×
“1224 siRNA was barely detectable or absent, implying that these lymphomas eventually escape their dependence on Trp53 knockdown through additional genetic alterations, consistent with a previous repor”
Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells
Loonstra, A., Vooijs, M., Beverloo, H. B., Allak, B. A., van Drunen, E., Kanaar, R., Berns, A., & Jonkers, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161269798 · Cited by 590
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538 · cited 1×
“Furthermore, acute disruption of gene function can circumvent genetic compensatory mechanisms inherent to germline mutant model”
Stegmeier, F., Hu, G., Rickles, R. J., Hannon, G. J., & Elledge, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506306102 · Cited by 532
Self-citationProbing tumor phenotypes using stable and regulated synthetic microRNA precursors
Dickins, R. A., Hemann, M. T., Zilfou, J. T., Simpson, D. R., Ibarra, I., Hannon, G. J., & Lowe, S. W. (2005) · Nature Genetics · doi:10.1038/ng1651 · Cited by 524
Self-citationINK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R., & Lowe, S. W. (1999) · Genes & Development · doi:10.1101/gad.13.20.2670 · Cited by 458 · cited 1×
“Eμ-Myc lymphomagenesis is markedly accelerated by Trp53 deficienc”
Self-citationComparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene
Kim, M., Gans, J. D., Nogueira, C., Wang, A., Paik, J.-H., Feng, B., Brennan, C., Hahn, W. C., Cordon-Cardo, C., Wagner, S. N., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.008 · Cited by 392
Self-citationThe temporal requirement for endothelin receptor-B signalling during neural crest development
Shin, M. K., Levorse, J. M., Ingram, R. S., & Tilghman, S. M. (1999) · Nature · doi:10.1038/990040 · Cited by 354
Hemann, M. T., Fridman, J. S., Zilfou, J. T., Hernando, E., Paddison, P. J., Cordon-Cardo, C., Hannon, G. J., & Lowe, S. W. (2003) · Nature Genetics · doi:10.1038/ng1091 · Cited by 354
Self-citationMidgley, C. A., Owens, B., Briscoe, C. V., Thomas, D. B., Lane, D. P., & Hall, P. A. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.5.1843 · Cited by 235
NFκB Mediates Apoptosis through Transcriptional Activation of Fas (CD95) in Adenoviral Hepatitis
Kühnel, F., Zender, L., Paul, Y., Tietze, M. K., Trautwein, C., Manns, M., & Kubicka, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6421 · Cited by 163
Self-citationValidating cancer drug targets
Benson, J. D., Chen, Y.-N. P., Cornell-Kennon, S. A., Dorsch, M., Kim, S., Leszczyniecka, M., Sellers, W. R., & Lengauer, C. (2006) · Nature · doi:10.1038/nature04873 · Cited by 161
Self-citationCurrent issues in mouse genome engineering
Glaser, S., Anastassiadis, K., & Stewart, A. F. (2005) · Nature Genetics · doi:10.1038/ng1668 · Cited by 160 · cited 1×
“Conditional gene inactivation can also be achieved using site-specific recombination systems, including Cre/ lox P and Flp/ FRT”
Tuning silence: conditional systems for RNA interference
Wiznerowicz, M., Szulc, J., & Trono, D. (2006) · Nature Methods · doi:10.1038/nmeth914 · Cited by 118
Rao, M. K., Pham, J., Imam, J. S., MacLean, J. A., Murali, D., Furuta, Y., Sinha-Hikim, A. P., & Wilkinson, M. F. (2006) · Genes & Development · doi:10.1101/gad1367806 · Cited by 115
Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference
Coumoul, X. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni100 · Cited by 90
Xia, X.-G., Zhou, H., Samper, E., Melov, S., & Xu, Z. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020010 · Cited by 84
Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis.
Hsu, B., Marín, M. C., El‐Naggar, A. K., Stephens, L. C., Brisbay, S. M., & McDonnell, T. J. (1995) · PubMed · Cited by 83
Reversibility of oncogene-induced cancer
Felsher, D. W. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.12.008 · Cited by 78
Reproducible and inducible knockdown of gene expression in mice
Yu, J., & McMahon, A. P. (2006) · genesis · doi:10.1002/dvg.20213 · Cited by 60
Conditional gene knock‐down by CRE‐dependent short interfering RNAs
Fritsch, L., Martinez, L. A., Sekhri, R., Naguibneva, I., Gérard, M., Vandromme, M., Schaeffer, L., & Harel‐Bellan, A. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400064 · Cited by 59
p53 Represses CAAT Enhancer-binding Protein (C/EBP)-dependent Transcription of the Albumin Gene
Kubicka, S., Kühnel, F., Zender, L., Rudolph, K. L., Plümpe, J., Manns, M., & Trautwein, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32137 · Cited by 50
Self-citation"Outbreak of hind limb paralysis in young CFW Swiss Webster mice".
Ceccarelli, A. V., & Rozengurt, N. (2002) · PubMed · Cited by 9
Cited by
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
“Animals Genotyping protocols of p53 / , INK4a/Arf / and TRE-shp53 mice were previously described (Dickins et al., 2007; Schmitt et al., 2002).”
BackgroundMethodSelf-citationPrinciples of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
“Third, RNAi can be readily applied to animal models (Dickins et al., 2007).”
Tumor Suppressive Functions of p53
Zilfou, J. T., & Lowe, S. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001883 · Cited by 575
“Similar data were reported through the utilization of an inducible RNAi-based strategy to reactivate p53 in in vitro and in vivo (Dickins et al. 2005; Dickins et al. 2007).”
MethodSelf-citationMarkstein, M., Pitsouli, C., Villalta, C., Celniker, S. E., & Perrimon, N. (2008) · Nature Genetics · doi:10.1038/ng.101 · Cited by 515
“For example, in a promising proof-of-principle experiment demonstrating inducible transgenic RNAi in the mous”
BackgroundGenetically engineered mouse models in oncology research and cancer medicine
Kersten, K., de Visser, K. E., van Miltenburg, M. H., & Jonkers, J. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606857 · Cited by 502
“Moreover, the development of systems for doxycycline-inducible shRNA expression in transgenic mice allows reversible expression of shRNAs in a time-and tissue-specific manner (Dickins et al , 2007; Premsrirut et al , 2011).”
Metadata
- Authors
- Dickins, R. A., McJunkin, K., Hernando, E., Premsrirut, P. K., Krizhanovsky, V., Burgess, D. J., Kim, S. Y., Cordon-Cardo, C., Zender, L., Hannon, G. J., & Lowe, S. W.
- Affiliations
- Howard Hughes Medical Institute (US)
- Cold Spring Harbor Laboratory (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Lowe, Scott W
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-06-17
- Volume
- 39
- Issue
- 7
- Pages
- 914-921
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC4595852
- OpenAlex
- W2169151715
- Cited by
- 174
- References
- 39
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 8 · 2016: 6 · 2015: 12 · 2014: 17 · 2013: 19 · 2012: 14
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- National Cancer Institute (P01CA087497, P01CA013106, P30CA008748)
- National Institute of General Medical Sciences (T32GM008444)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- RNA interference, shRNA, microRNA, Trp53, tissue-specific gene regulation, lymphoma, tumor regression, transgenic mice, endogenous gene expression
- MeSH terms
- Animals, Mice, Transgenic, Organ Specificity, Promoter Regions, Genetic, Tetracycline, Drug Delivery Systems, RNA Interference, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.